ABVX - Abivax - ADR
IEX Last Trade
12.75
0.050 0.392%
Share volume: 92,547
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.70
0.05
0.39%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
9.57%
1 Month
7.44%
3 Months
-4.72%
6 Months
-8.10%
1 Year
53.13%
2 Year
53.13%
Key data
Stock price
$12.75
DAY RANGE
N/A - N/A
52 WEEK RANGE
$8.00 - $17.02
52 WEEK CHANGE
$0.53
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: http://www.abivax.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.abivax.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news